MIRA Pharmaceuticals, Inc. (MIRA) Q1 2026 Annual Earnings
MIRA·Reported May 14, 2026·Before market open
Diluted EPS came in at $-0.03 (+72.7% YoY).
Diluted EPS
$-0.03
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about MIRA Pharmaceuticals, Inc.'s Q1 2026 earnings report.
MIRA Pharmaceuticals, Inc. (MIRA) reported Q1 2026 earnings on May 14, 2026 before market open.
MIRA Pharmaceuticals, Inc. reported diluted EPS of $-0.03 for Q1 2026.
Compared to the same quarter a year prior, diluted EPS grew 72.7% from $-0.11.
You can read the 8-K earnings release (0001493152-26-022608) and the 10-K periodic report (0001493152-26-014001) directly on SEC EDGAR. The filing index links above go to sec.gov.